RxDoctor Payments Data

Jan Burger, MD

Family Medicine · Summerville, SCNPI 1215001979

Payments from drug & device makers

$15,552in general payments, 2019–2025

Across 855 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • Pfizer$1K
  • Amgen$814
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$15,551100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)117$1,693
AstraZeneca56$1,529
Lilly USA, LLC75$1,460
Novo Nordisk93$1,330
Pfizer67$1,080
Amgen(2 entities)47$814
GSK49$801
Supernus Pharmaceuticals, Inc.23$694
Bayer23$457
Boehringer Ingelheim22$437
Amarin Pharma, Inc.23$418
Johnson & Johnson24$363
Exact Sciences18$359
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$312
Novartis16$250
Antares Pharma, Inc.11$193
Corium, LLC7$189
Takeda Pharmaceuticals U.S.A., Inc.12$176
Biohaven Pharmaceutical Holding Company Ltd.8$171
Biohaven Pharmaceuticals, Inc.9$169
Astellas Pharma US Inc8$167
Phathom Pharmaceuticals, Inc.8$166
Idorsia Pharmaceuticals US Inc8$147
Shield Therapeutics Inc7$138
Teva Pharmaceuticals USA, Inc.10$138
Esperion Therapeutics, Inc.7$133
Xeris Pharmaceuticals, Inc.5$102
Harmony Biosciences LLC3$101
Upsher-smith Laboratories LLC6$99
Mylan Specialty L.p.5$93
Sanofi-aventis U.S. LLC5$92
Sumitomo Pharma America, Inc.3$79
Edwards Lifesciences2$75
Dexcom, Inc.3$74
Averitas Pharma Inc.1$69
Bausch Health US, LLC3$68
Kowa Pharmaceuticals America, Inc.5$65
Genentech USA, Inc.4$61
Axsome Therapeutics, Inc.2$61
Boston Scientific4$58
Jazz Pharmaceuticals Inc.3$57
Eisai Inc.4$56
Merck3$53
Shire North American Group Inc3$44
Avanir Pharmaceuticals, Inc.2$43
Abbott2$41
Currax Pharmaceuticals LLC3$39
Inspire Medical Systems, Inc.1$29
Radius Health, Inc.1$23
Tonix Medicines, Inc.1$22
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$21
Renalytix AI, Inc.1$21
Sunovion Pharmaceuticals Inc.1$19
Hikma Pharmaceuticals USA1$19
Seqirus USA Inc1$18
Corcept Therapeutics1$18
Sonex Health, Inc.1$17
Almatica Pharma LLC1$17
Kettenbach LP1$16
Amneal Pharmaceuticals LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,552 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$411,436
Medicare patients
730
Services billed
11,615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide100$146,750
MounjaroTirzepatide104$139,760
Xigduo XrDapaglifloz Propaned/Metformin58$65,046
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$55,491
EliquisApixaban57$53,790
FarxigaDapagliflozin Propanediol47$45,612
JardianceEmpagliflozin28$30,699
XareltoRivaroxaban11$15,930
Janumet XrSitagliptin Phos/Metformin Hcl11$13,978
LinzessLinaclotide12$12,029
Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate16$8,260
Rosuvastatin Calcium423$7,281
Atorvastatin Calcium777$6,192
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$5,412
Omeprazole393$5,249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,330$146,750100 claims
Lilly USA, LLCMounjaro$1,460$139,760104 claims
PfizerEliquis, Premarin$1,080$57,62269 claims
GSKTrelegy Ellipta$801$55,49140 claims
AstraZenecaFarxiga, Symbicort$1,529$50,74862 claims
Boehringer IngelheimJardiance$437$30,69928 claims
Johnson & JohnsonXarelto$363$15,93011 claims
AbbVieLinzess, Synthroid$1,693$14,19341 claims
MerckJanumet Xr$53$13,97811 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$4,367507 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Summerville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →